Financials

  • Market Capitalization 4.37 B
  • Employee 798
  • Founded 1993
  • CEO Catherine Owen Adams
  • Website www.acadia.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHG9K0
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
11.61
Price to sales ratio
4.24

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1424
EWTX
Edgewise Therapeutics, Inc. - Common Stock
41.27 USD-9.12%+1.90%+16.45%+170.98%4.44 B USD
1425
VKTX
Viking Therapeutics, Inc. - Common Stock
38.12 USD-1.90%-2.48%+30.82%+20.06%4.43 B USD
1463
DNLI
Denali Therapeutics Inc. - Common Stock
26.48 USD+3.12%+2.12%+21.13%+63.76%4.20 B USD
1478
TNGX
Tango Therapeutics, Inc. - Common Stock
28.36 USD-8.69%-6.43%-9.48%+358.16%4.10 B USD

Frequently asked questions about ACADIA Pharmaceuticals Inc. - Common Stock

What is the ACADIA Pharmaceuticals Inc. - Common Stock stock price today?

The current price of ACADIA Pharmaceuticals Inc. - Common Stock (ACAD) is 25.5. Over the past 24 hours, the stock has changed by -2.75%. Follow the ACAD chart for real-time price dynamics.

What is the stock ticker of ACADIA Pharmaceuticals Inc. - Common Stock?

ACADIA Pharmaceuticals Inc. - Common Stock trades under the ticker ACAD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is ACADIA Pharmaceuticals Inc. - Common Stock stock going up?

ACAD has changed by -2.52% over the last week, +20.85% over the last month, and +16.23% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was ACADIA Pharmaceuticals Inc. - Common Stock net income for the last quarter?

ACADIA Pharmaceuticals Inc. - Common Stock reported net income of 3.64 M for the last quarter. The previous quarter showed 273.57 M, which means net income changed by -98.67%.

How many employees does ACADIA Pharmaceuticals Inc. - Common Stock have?

As of the latest available data, ACADIA Pharmaceuticals Inc. - Common Stock has 798 employees. Workforce size can provide additional context about the company's scale and operations.

What is ACADIA Pharmaceuticals Inc. - Common Stock EBITDA?

ACADIA Pharmaceuticals Inc. - Common Stock EBITDA is -2.08 M, and its EBITDA margin is -0.77%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy ACADIA Pharmaceuticals Inc. - Common Stock stock?

You can buy ACADIA Pharmaceuticals Inc. - Common Stock (ACAD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in ACADIA Pharmaceuticals Inc. - Common Stock stock?

Investing in ACADIA Pharmaceuticals Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ACAD chart and related analysis on metatrader.com as part of your research.

ACADIA Pharmaceuticals Inc. - Common Stock

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.

News